in this issue
Chemical Week Magazine :: Newsbriefs
Akzo Nobel Restates Plan to List Pharma Business
1:47 PM MDT | July 25, 2007 | Chemical Week Editorial Staff
Akzo Nobel has restated its intention to divest a 20%-30% stake in its Organon BioSciences (OBS) pharmaceuticals business early this year through an initial public offering, quashing speculation that Akzo will sell OBS to a consortium of private equity companies. “Over the last few weeks, Akzo has received preliminary expressions of interest from a number of parties regarding an acquisition of OBS,” the company says. “Akzo has carefully reviewed these proposals and reconfirms that it remains committed to a separate listing for OBS.”...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee